Consumer Health & Personal Care

Thematic deep dive report by NKP | M&A Insights - 20 October 2026

Summary

This thematic deep dive covers 30 emerging, live, and paused M&A opportunities in Consumer Health & Personal Care across Northern Europe, with target names withheld (available to subscribers). Each is profiled by EBITDA, EBITDA margin, revenue growth, HQ, fiscal year, and NKP coverage dates.

The set spans the full size range — from a Sweden-headquartered pan-European nutritional-supplements CDMO at EUR 68–92m EBITDA down to a UK skincare/haircare brand running slightly EBITDA-negative. Across the cohort, the median EBITDA margin is 20.0% and median revenue growth is 15.7%, though growth varies widely, from an EUR 34–46m hair-care brand compounding at +100% to several low-single-digit and negative growers. Supplements, DTC nutrition, cosmetics, and contract manufacturing (CDMO/CDMC) dominate the mix; Germany and the UK are the most represented HQ geographies, followed by the Nordics, Benelux, Switzerland, and Austria.

The report also tracks valuation development across 265 historical transactions (Europe and US, 2018–2026 YTD). Median EV/EBITDA held in a tight ~11.6–12.4x band from 2018 to 2022, spiked to 19.3x in 2023, reset to 11.8x in 2024, and has since recovered to 13.1x in 2025 and 15.4x in 2026 YTD — leaving current pricing above the pre-2023 baseline but below the 2023 peak.